Sipuleucel-T: Autologous Cellular Immunotherapy for Men with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

od Sims, Robert B.
Izdano 2011

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer

od Mouraviev, Vladimir, Mariados, Neil, Albala, David, Concepcion, Raoul S, Shore, Neal D, Sims, Robert B, Emberton, Mark, Pieczonka, Christopher M
Izdano 2014

A Transient Increase in Eosinophils is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T

od McNeel, Douglas G., Gardner, Thomas A., Higano, Celestia S., Kantoff, Philip W., Small, Eric J., Wener, Mark H., Sims, Robert B., DeVries, Todd, Sheikh, Nadeem A., Dreicer, Robert
Izdano 2014

A Phase 1 Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu

od Peethambaram, Prema P., Melisko, Michelle E., Rinn, Kristine J., Alberts, Steven R., Provost, Nicole M., Jones, Lori A., Sims, Robert B., Lin, Lisa R.C., Frohlich, Mark W., Park, John W.
Izdano 2009

Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer

od Fong, Lawrence, Carroll, Peter, Weinberg, Vivian, Chan, Stephen, Lewis, Jera, Corman, John, Amling, Christopher L., Stephenson, Robert A., Simko, Jeffrey, Sheikh, Nadeem A., Sims, Robert B., Frohlich, Mark W., Small, Eric J.
Izdano u J Natl Cancer Inst (2014)